Just six weeks afterwards, the DEA designed an unprecedented announcement that it had been withdrawing its detect of intent. This was resulting from 1000s of public responses, mainly from people, urging the DEA to reconsider. Importantly, the DEA stated that it could also take into account conducting a scientific and health care analysis of kratom.